YiZhouMDPhD

Pathology • Winston Salem, NC

Gastrointestinal & Hepatobiliary Pathology, Anatomic Pathology, Clinical Pathology, Surgical Pathology

Assistant professor

Join to view full profile

Dr. Zhou is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Zhou's full profile

Already have an account?

Office
Medical center boulevard
Winston Salem, NC 27157

Summary

Dr. Yi Zhou is a pathologist in Winston Salem, NC and is affiliated with multiple hospitals in the area, including Wake Forest Baptist Medical Center.She received her fellowship training in GI pathology and oncologic surgical pathology at MSKCC. She is experienced in general surgical pathology, GI/ liver pathology, and has 6 years of experience in a big academic medical center.

Education & Training

Memorial Sloan Kettering Cancer Center Oncologic PathologyFellowship, Selective Pathology, 2013 - 2014
Memorial Sloan Kettering Cancer CenterFellowship, Oncologic Pathology, 2012 - 2013
University of Illinois College of Medicine at ChicagoResidency, Pathology-Anatomic and Clinical, 2008 - 2012
Peking Union Medical CollegeClass of 1998

Certifications & Licensure

NC State Medical License 2016 - 2025
NJ State Medical License 2021 - 2025
NY State Medical License 2021 - 2025
IL State Medical License 2008 - 2017
American Board of Pathology Anatomic Pathology & Clinical Pathology
American Board of Pathology Pathology - Anatomic/Pathology - Clinical

Publications & Presentations

PubMed

1 citations
Mucin-containing rectal cancer: a review of unique imaging, pathology, and therapeutic response features
David D. Childs, Caio Max Sao Pedro Rocha Lima, Yi Zhou
Seminars in Roentgenology. 2021-04-01
4 citations
Intraductal papillary neoplasm of the left hepatic duct treated with endoscopic retrograde cholangiopancreatography guided radiofrequency ablation.
Steven Delaney, Yi Zhou, Swati Pawa, Rishi Pawa
Clinical Journal of Gastroenterology. 2021-02-01
141 citations
The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies.
Richard Copin, Alina Baum, Elzbieta Wloga, Kristen E. Pascal, Stephanie Giordano
Cell. 2021-01-01

Journal Articles

Collagenous Sprue. 2019 Dec 14
Rejeski J, Conway J, Zhou Y., Am J Med Sci., 12/14/2019
Metastatic Well-Differentiated Neuroendocrine Tumor in the Breast: A Case Report and Literature Review.
Yu D, Zhou Y., Hum Pathol: case rep., 2019 Sep, 9/2019
Intrahepatic Cholangiocarcinomas Have Histologically and Immunophenotypically Distinct Small and Large Duct Patterns.
Sigel CS, Drill E, Zhou Y, Basturk O, Askan G, Pak LM, Vakiani E, Wang T, Boerner T, Do RKG, Simpson AL, Jarnagin W, Klimstra DS., Am J Surg Pathol. 2018, 7/13/2018
Cerebellar EBV-associated diffuse large B-cell lymphoma following angioimmunoblastic T-cell lymphoma.
Zhou Y, Rosenblum MK, Dogan A, Jungbluth AA, Chiu A., J Hematop. 2015 Dec 8(4):235-41., 12/8/2015
Immunohistochemical Detection of the BRAF V600E Mutant Protein in Colorectal Neoplasms.
Vakiani E, Yaeger R, Brooke S, Zhou Y, Klimstra DS, Shia J., Appl Immunohistochem Mol Morphol. 2014 Dec 16., 12/14/2014
Immunohistochemical detection of ARID1A in colorectal carcinoma: loss of staining is associated with sporadic microsatellite unstable tumors ...
Ye J, Zhou Y, Weiser, MR, Gonen M, Zhang L, Samdani T, Bacares R, Delair D, Ivejia S, Vakiani, E, Klimstra DS, Soslow RA, Shia J., Hum Pathol.2014. 2014 Dec;45(12):2430-6, 12/2014
Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence.
Gruessner C, Gruessner A, Glaser K, AbuShahin N, Zhou Y, Laughren C, Wright H, Pinkerton S, Yi X, Stoffer JB, Azodi M, Zheng W, Chambers SK., Cancer Prev Res (Phila). 2014, 9/2014
Is pneumatosis cystoides intestinalis gas- distended and ruptured lymphatics?: reappraisal by immunohistochemistry.
Gui X, Zhou Y, Eidus L, Falck V, Gao ZH, Qin L., Arch Pathol Lab Med. 2014 Aug;138(8):1059-66., 8/2014
Hydralazine- Induced Vasculitis With Gastrointestinal Pseudomelanosis.
Novikov A, Zhou Y, Glockenberg K, Kumta N, Cohen M, Mehta M, Wan D., ACG Case Rep J 2014;2(1)., 2014
Multiple osteolytic lesions and urine monoclonal kappa light chains as presenting signs of chronic vasculitis and reactive hemophagocytic lymphohistiocytosis. ...
Zhou Y, Rondelli D, Gaitonde S., www.bloodmed.com, 2/2010
Regulation of non-AU-rich element containing c-fms proto-oncogene expression by HuR in breast cancer.
Woo HH, Zhou Y, Yi X, David CL, Zheng W, Gilmore-Hebert M, Kluger HM, Ulukus EC, Baker T, Stoffer JB, Chambers SK., Oncogene. 2009 Mar 5;28(9):1176-86., 3/2009
HuR expression in the nucleus correlates with high histological grade and poor disease-free survival in ovarian cancer.
Yi X, Zhou Y, Zheng W, Chambers SK., Aust N Z J Obstet Gynaecol. 2009 Feb;49(1):93-8., 2/2009
The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancer.
Zhou Y, Yi X, Stoffer JB, Bonafe N, Gilmore-Hebert M, McAlpine J, Chambers SK., Mol Cancer Res. 2008 Aug;6(8):1375-84., 8/2008
Glyceraldehyde-3-phosphate dehydrogenase binds to the AU-Rich 3' untranslated region of colony-stimulating factor-1 (CSF-1) messenger RNA in human ovarian cancer cells...
Bonafe N, Gilmore-Hebert M, Folk NL, Azodi M, Zhou Y, Chambers SK., Cancer Res., 65(9): 3762-71, 2005., 2005
Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features.
Liang SX, Chambers SK, Cheng L, Zhang S, Zhou Y, Zheng W., Int J Surg Pathol., 12(4): 319-31, 2004., 2004
Join now to see all